Topics
Treatment, Biology / Mechanism, Outcomes / Survival
Modality
Targeted therapy, Imaging
Study type
Not listed
Abstract
By virtue of its function as a key metabolic regulator, malignant transformation in the pancreas not only confers high aggressiveness but also disrupts systemic metabolism. However, the causal relationship between metabolic reprogramming and the progression of pancreatic ductal adenocarcinoma (PDAC) remains incompletely understood. This…
Authors
Junxiang Wen, Qiuchen Li, Shuxiang Xu, Wenjun Lu +3
AI-generated summary
HHEX-PRKAR2B axis-mediated PKA activation drives glucose metabolism-dependent progression of pancreatic ductal adenocarcinoma. reports: By virtue of its function as a key metabolic regulator, malignant transformation in the pancreas not only confers high aggressiveness but also disrupts systemic metabolism. However, the causal relationship between metabolic reprogramming and the progression of pancreatic ductal adenocarcinoma (PDAC) remains incompletely understood. This study identifies aberrant protein kinase A (PKA) activation in PDAC, correlating with poor prognosis.
This summary may be inaccurate. Verify with the primary paper.
Primary source: PubMed.